Jersey student leads project to recreate fatty liver disease
A Jersey student aims to better understand fatty liver disease by re-creating it in a dish. Millie-Rose Doolan, who grew up in St Brelade, has plans to use patient-donated liver samples to develop 3D tissue cultures that are derived from stem, progenitor or induced pluripotent cells. Fatty liver disease, also known as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), is a chronic liver condition that is initiated by having too much fat in the liver. Ms Doolan, who is studying for her PhD at the University of Southampton, said: "By creating 3D organoids using patient tissue we can delve deeper into how the disease progresses and identify potential targets for treatment."
Global health problem
MASLD is significantly associated with central obesity, as well as conditions such as type 2 diabetes and heart and circulatory disease. It is estimated to affect up to one in five people in the UK, but rates are increasing with rising levels of metabolic diseases such as obesity.Ms Doolan said: "Fatty liver disease is a global health problem – latest figures suggest that up to 30% of the global adult population will be affected."The underlying biology of MASLD progression is unclear, and not all patients progress at the same rate or develop severe disease."
Currently, MASLD research is limited by a lack of experimental systems that replicate what happens in different humans. Some laboratory tests can recapitulate aspects of MASLD progression but there are significant differences to what happens in the human body or a given individual.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
2 days ago
- BBC News
AI to help tell donkeys apart at Isle of Wight sanctuary
Visitors to a donkey sanctuary will be able to identify their favourite adopted animal using artificial intelligence (AI) and their phone camera, researchers of Southampton scientists developing the mobile app - being used at the Isle of Wight Donkey Sanctuary - said they hoped it could also help identify health issues in the app uses a library of hundreds of photographs of the donkeys from every angle, utilising machine-learning and AI to distinguish them from one still has a way to go, with the app having a coin-flip accuracy of only 50% at the moment. But project lead Dr Xiaohao Cai said he was confident it would be much improved and ready for the public to use by the end of the year."At the moment we're trying to bridge the gap between the experimental accuracy and the real-world accuracy," said Dr Cai. The idea emerged after it was noticed name collars worn by the donkeys were becoming hazardous and uncomfortable, said Gordon Pattison, volunteer and trustee of the sanctuary in Ventnor. "There had been some accidents and near misses, so we got rid of all the collars in 2023," said Mr Pattison. "They're not of any use to the animal, but they're incredibly useful to the public - some of whom will come and want to see a particular animal."The sanctuary raises funds by allowing visitors to adopt a donkey - something Mr Pattison said thousands of people had signed up to do. The app is called Ask ELVIS (Equine Long-range Visual Identification System), named after one of the sanctuary's donkeys who died in 2024 and was described by staff as an "iconic character". "When the app starts up, you see Elvis the donkey, and the idea is you're asking a donkey, 'who's that donkey over there?'" said Mr Pattison. The app will then show the donkey's name and a link to webpage where visitors can learn more about that animal. And asked if donkeys respond to their name, Mr Pattison said they do. He said in future the sanctuary hoped to work with scientists from the university to see if AI could also help monitor for health issues in the animals - but that project has not got off the ground yet. "At the moment we will pick it up (the health issue), but we might not pick it up immediately," he said. "[The donkeys] don't give out much, they're very stoic - so we have to look for subtle clues," he added. "The message is that AI isn't just for big state enterprises."If you've got an idea, it can help you out - you just need to approach the problem from a different point of view." You can follow BBC Hampshire & Isle of Wight on Facebook, X (Twitter), or Instagram.
BBC News
4 days ago
- BBC News
Study investigates how to support grieving families
A man whose two-year-old son died after contracting sepsis says he "dreads to think" where he and his family would be without the support they from Guildford in Surrey, said Shooting Star Children's Hospices helped him realise he was not alone in his grief following the death of his son Monty in said grieving families were "not alone" and "you don't have to lock yourself away".Shooting Star is now collaborating with experts from the University of Southampton on a project to investigate and make recommendations to improve support for those who experience the unexpected death of a child. The group of hospices said it was one of only two in the country to have created a specialist bereavement service for families whose child had died suddenly or described the support from the hospice's counselling programme as "phenomenal".Now the £1.2m-study from Shooting Star, called Quinet, will see researchers run a national survey of bereaved team will also interview health professionals and other caregivers as part of the study that involves the universities of Surrey, Central Lancashire and Birmingham. Anne-Sophie Darlington, co-lead investigator for the study, said: "Surprisingly little is understood about the very complex needs of families when they experience the deep trauma of the sudden death of a child and it is crucial that we gain evidence about their care needs and what helps them cope in the longer term."The study will make recommendations for change in 2027.
The Sun
4 days ago
- The Sun
Blood test to detect early signs of deadliest cancer trialled in UK – and doctors are calling for people to take part
A NEW blood test to pick up early signs of a cancer which kills more than half of people within three months of diagnosis is being trialled by UK doctors. The genomic test uses blood samples to look for markers of the deadly disease, which often has vague symptoms. 2 Currently, the UK doesn't have a national screening programme for pancreatic cancer like it does for breast or bowel cancer. A huge issue is the disease is often diagnosed at a late stage because it frequently lacks noticeable symptoms in the early stages. But a new pancreatic cancer test is being trialled in patients with a recent diagnosis of type 2 diabetes - a known risk factor for the disease. People over 50 with a new case of type 2 diabetes have a higher chance of also being diagnosed with pancreatic cancer within three years. Early data suggests the Avantect test is 68 per cent accurate in picking up people with early stages of the disease, which kills almost 10,000 people every year in the UK. It's also 97 per cent accurate in ruling out people without pancreatic cancer. The new clinical trial has been launched at the Cancer Research UK Southampton Clinical Trials Unit. Zaed Hamady, consultant surgeon and pancreatic researcher at the University of Southampton, who's leading the trial, said: "There is currently no targeted early detection or surveillance test for the disease meaning patients are often diagnosed late when they become really unwell. "If we can develop approaches to detect the cancer sooner, then there are more options we may consider to treat the disease, and patients will have a much better chance of long-term survival. "Although most people with diabetes will not go on to develop the disease, new onset diabetes is associated with a six to eight-fold increased risk. "This patient group gives us a way to test how accurate the new diagnostic blood test is, and that could potentially help thousands of people in the future." According to researchers, newly-diagnosed type 2 diabetes patients often have similar symptoms as a person with early-stage pancreatic cancer. This is because the cancer destroys the same insulin-producing cells that are also destroyed in diabetes. 'Earlier diagnosis would have meant time to make more memories with our children' Sean Cleghorn's wife, Allison, discovered she had pancreatic cancer at Christmas 2020 but died four weeks later aged 54. Mr Cleghorn, a father of three from Kingsclere in Hampshire, said: "The only symptom Allison displayed was some slight indigestion and then she was diagnosed with type 2 diabetes in the autumn of 2020. "Allison had always eaten healthily, was active and avoided processed food, so this diagnosis was puzzling for us. "When we learned that new-onset type 2 diabetes was a potential risk factor for pancreatic cancer, we asked for further testing and a scan confirmed she had terminal cancer. "We hoped she could have chemotherapy to prolong her life, but she became too weak and died four weeks later. "Perhaps if she had been diagnosed sooner with a test like the one that's currently being trialled, we may have had time to make more memories with our three children." Angelica Cazaly, senior trial manager for the trial, said: "We are asking people with newly diagnosed type 2 diabetes who are attending GP surgeries or diabetic clinics whether they would like to take part in the study. "Initially, we will collect blood samples from 800 people for testing. "The results from the test, together with medical information collected from each patient, will help provide researchers with important information on how best to proceed with the rest of the study that will evaluate how accurate the test is at predicting pancreatic cancer." 'Exciting time for early detection research' 2 Around 10,500 people in the UK are diagnosed with pancreatic cancer every year and just one in 20 survive the disease for 10 years or more. Samuel Levy, chief scientific officer of ClearNote Health, said: "Our early data demonstrate that our Avantect test can identify pancreatic cancer in stages I and II. "We are excited to collaborate with the Cancer Research UK Southampton Clinical Trials Unit and the University Hospital Southampton NHS Foundation Trust on this transformative study that could redefine how pancreatic cancer is detected and managed for patients at high risk." Dr Chris Macdonald, head of research at Pancreatic Cancer UK, said over 80 per cent of people with pancreatic cancer are currently diagnosed too late for treatment. He added: "This is an exciting time for early detection research, with tests using blood, breath and urine in development which, if shown to be successful in clinical trials, could save thousands of lives every year. "Early findings from these tests are very promising, but more research is needed to ensure that they are as accurate as possible before they will be available in the GP surgery."
